Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$32,000.00
Apr 1, 2026
For-profit organization
StressMarq Biosciences Inc.-2026-2027-1041679
1041679
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$30,000.00
May 31, 2024
For-profit organization
StressMarq Biosciences Inc.-2024-2025-1026553
1026553
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$146,000.00
Apr 1, 2023
For-profit organization
Development of a quantitative assay of mutant proteins in neurodegenerative disease
1005184
This project aims to generate materials that can be used in an protein-based amplification assay that can determine the presence of prion-like aggregates in biological samples.
$17,250.00
Apr 1, 2021
For-profit organization
Stressmarq Biosciences Inc.-2021-2022-973607
973607
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$50,925.00
Aug 18, 2020
For-profit organization
Improved European Market Penetration of Neurodegenerative Disease Research Tools
956046
Stressmarq Biosciences Inc. Has developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research.
$227,000.00
May 1, 2020
For-profit organization
Development of oligomeric forms of prion-like proteins.
948559
This project will develop techniques to generate active, soluble oligomeric constructs of prion-like proteins relevant in neurological disease, including Tau, alpha synuclein and Abeta, using a variety of physical and chemical techniques.
$21,000.00
Apr 1, 2020
For-profit organization
Enhanced European Market Penetration of Neurodegenerative Disease Research Tools
947693
Stressmarq Biosciences Inc. Has developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research.
$232,248.00
Jun 1, 2018
For-profit organization
Development of protein and antibody products for Parkinson's Disease research and treatment
908924
Development of a suite of proteins, antibodies, and assays for use in Parkinson’s Disease research and an antibody to treat the disease.